Stereotaxis, Inc. (STXS)
NYSE · Electromedical & Electrotherapeutic Apparatus · Manufacturing · CIK 1289340 · fiscal year ends in Dec
Closing price $0.86 on 30 Oct 2026; 52-week range $0.86 to $2.92.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $30.1M
- Revenue growth
- -5.5%
- Net income, last twelve months
- -$22.3M
- Earnings per share
- -$0.24
- Gross margin
- 55.6%
- Operating margin
- -75.7%
- Net margin
- -74.2%
- Return on equity
- -182.3%
- Market value
- $85.8M
- Cash
- $10.5M
- Debt
- $0
- Debt to equity
- 0.00
- Shares outstanding
- 100.2M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $32.4M | -$22.1M | -$21.6M | -$0.25 | -$13.8M | 10-K filed 12 Mar 2026 |
| FY2024 | 31 Dec 2024 | $26.9M | -$24.7M | -$24.0M | -$0.30 | -$8.5M | 10-K filed 14 Mar 2025 |
| FY2023 | 31 Dec 2023 | $26.8M | -$21.8M | -$20.7M | -$0.27 | -$9.5M | 10-K filed 8 Mar 2024 |
| FY2022 | 31 Dec 2022 | $28.1M | -$18.8M | -$18.3M | -$0.26 | -$10.8M | 10-K filed 9 Mar 2023 |
| FY2021 | 31 Dec 2021 | $35.0M | -$12.9M | -$10.7M | -$0.16 | -$4.3M | 10-K filed 10 Mar 2022 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $7.7M | -$4.5M | -$0.05 |
| Q1 FY2026 | 31 Mar 2026 | $6.3M | -$5.9M | -$0.06 |
| Q4 FY2025 | 31 Dec 2025 | $8.6M | -$5.5M | -$0.06 |
| Q3 FY2025 | 30 Sep 2025 | $7.5M | -$6.5M | -$0.07 |
| Q2 FY2025 | 30 Jun 2025 | $8.8M | -$3.8M | -$0.05 |
| Q1 FY2025 | 31 Mar 2025 | $7.5M | -$5.8M | -$0.07 |
| Q4 FY2024 | 31 Dec 2024 | $6.3M | -$7.5M | -$0.09 |
| Q3 FY2024 | 30 Sep 2024 | $9.2M | -$6.2M | -$0.08 |
Revenue by segment
As the company reports it in the segment note of its annual report.
By product, FY2025
| Segment | Revenue | Share |
|---|---|---|
| Disposables Service and Accessories | $22.2M | 68.4% |
| Systems | $10.2M | 31.6% |
By region, FY2025
| Segment | Revenue | Share |
|---|---|---|
| Non-US | $19.5M | 60.3% |
| United States | $12.9M | 39.7% |
Company events
The newest 8-K filings of 277 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 11 Aug 2026 | 8-K | Results | 2.02, 9.01 |
| 16 Jul 2026 | 8-K | Other events | 8.01, 9.01 |
| 9 Jul 2026 | 8-K | Share sale, Investor update, Other events | 3.02, 7.01, 8.01, 9.01 |
| 15 May 2026 | 8-K | Shareholder vote | 5.07 |
| 12 May 2026 | 8-K | Results | 2.02, 9.01 |
| 15 Apr 2026 | 8-K | Material agreement, Share sale, Investor update | 1.01, 3.02, 7.01, 9.01 |
| 9 Mar 2026 | 8-K | Results | 2.02, 9.01 |
| 12 Nov 2025 | 8-K | Results | 2.02, 9.01 |
| 29 Aug 2025 | 8-K | Material agreement | 1.01, 9.01 |
| 7 Aug 2025 | 8-K | Results | 2.02, 9.01 |
| 17 Jul 2025 | 8-K | Material agreement, Investor update | 1.01, 7.01, 9.01 |
| 17 Jul 2025 | 8-K | Results, Other events | 2.02, 8.01 |
Every filing
The newest filings with the SEC of 596 held.
| Filed | Form | Period |
|---|---|---|
| 13 Aug 2026 | EFFECT | – |
| 13 Aug 2026 | EFFECT | – |
| 12 Aug 2026 | 10-Q | 30 Jun 2026 |
| 11 Aug 2026 | 8-K | 11 Aug 2026 |
| 16 Jul 2026 | 8-K | 15 Jul 2026 |
| 15 Jul 2026 | S-3 | – |
| 15 Jul 2026 | S-3 | – |
| 9 Jul 2026 | 8-K | 7 Jul 2026 |
| 29 May 2026 | SD | – |
| 15 May 2026 | 8-K | 14 May 2026 |
| 13 May 2026 | 10-Q | 31 Mar 2026 |
| 12 May 2026 | 8-K | 12 May 2026 |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 17 Nov 2025 | Isaac Paul J, Director | Purchase | 10,000 | $2.18 | $21.8K | 97,299 | 18 Nov 2025 |
| 14 Nov 2025 | Isaac Paul J, Director | Purchase | 20,000 | $2.24 | $44.8K | 2,786,557 | 18 Nov 2025 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 19 Aug 2026 | Daniel Louis Kaufman | 13G | 5.9% | 6.0M |
| 15 May 2026 | Lagoda Investment Management, L.P. | 13G amended | 4.5% | 4.4M |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 6.0M | +5.46% | 10.18 |
| 30 Sep 2026 | 5.7M | +1.88% | 11.58 |
| 15 Sep 2026 | 5.6M | +10.39% | 10.09 |
| 31 Aug 2026 | 5.1M | -6.18% | 9.94 |
| 14 Aug 2026 | 5.4M | +20.13% | 7.04 |
| 31 Jul 2026 | 4.5M | +0.54% | 2.47 |
| 15 Jul 2026 | 4.5M | +4.58% | 6.67 |
| 30 Jun 2026 | 4.3M | +10.74% | 6.13 |
Funds that hold it
From each fund's latest Form 13F.
124 funds held it at 30 Jun 2026: 56 added and 22 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| Dafna Capital Management LLC | 13,680,554 | $23.5M | 0 |
| Arbiter Partners Capital Management LLC | 5,767,712 | $9.9M | – |
| BlackRock, Inc. | 4,396,835 | $7.6M | +440,592 |
| Lagoda Investment Management, L.P. | 4,122,600 | $7.1M | -227,800 |
| Vanguard Capital Management LLC | 3,044,820 | $5.2M | +46,776 |
| Geode Capital Management, LLC | 1,895,243 | $3.3M | +219,835 |
| Essex Investment Management Co. LLC | 1,521,966 | $2.6M | -68,135 |
| Archon Capital Management LLC | 1,226,044 | $2.1M | 0 |
| Warberg Asset Management LLC | 1,108,889 | $1.9M | +14,766 |
| State Street Corp. | 916,780 | $1.6M | -40,988 |
Peers
Companies in the same industry.
- Medtronic plc (MDT): revenue $37.5B, market value $123.6B
- LivaNova plc (LIVN): revenue $1.5B, market value $4.3B
- Integer Holdings Corp. (ITGR): revenue $1.8B, market value $4.3B
- Axogen, Inc. (AXGN): revenue $266.9M, market value $2.9B
- TransMedics Group, Inc. (TMDX): revenue $668.5M, market value $2.3B
- Conmed Corp. (CNMD): revenue $1.4B, market value $1.3B
- Ceribell, Inc. (CBLL): revenue $102.0M, market value $1.0B
- CapsoVision, Inc. (CV): revenue $13.9M, market value $341.7M
- Electromed, Inc. (ELMD): revenue $73.8M, market value $225.0M
- Edap TMS SA (FOCL): revenue –, market value $157.6M